GFA
BSX icon

Gallagher Fiduciary Advisors’s Boston Scientific BSX Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Sell
6,710
-1,619
-19% -$87.9K 0.01% 297
2026
Q1 		$523K Buy
8,329
+413
+5% +$33K 0.02% 152
2025
Q4 		$755K Buy
7,916
+403
+5% +$39.5K 0.02% 131
2025
Q3 		$733K Buy
7,513
+141
+2% +$14.6K 0.03% 104
2025
Q2 		$792K Buy
7,372
+263
+4% +$26.6K 0.03% 105
2025
Q1 		$717K Buy
7,109
+124
+2% +$12.5K 0.02% 122
2024
Q4 		$624K Buy
6,985
+802
+13% +$70.6K 0.12% 112
2024
Q3 		$518K Buy
6,183
+1,297
+27% +$102K 0.1% 112
2024
Q2 		$376K Buy
4,886
+1,798
+58% +$132K 0.08% 127
2024
Q1 		$211K Buy
+3,088
New +$199K 0.01% 184

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gallagher Fiduciary Advisors's BSX Position: Q2 2026 in Review

Gallagher Fiduciary Advisors reduced its Boston Scientific (BSX) stake by 19% in Q2 2026, selling an estimated $87.9K and leaving 6,710 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #297.

Gallagher Fiduciary Advisors first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $792K in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Gallagher Fiduciary Advisors held 6,710 shares of Boston Scientific worth $286K as of Q2 2026.
  • Gallagher Fiduciary Advisors sold 1,619 Boston Scientific shares in Q2 2026, an estimated $87.9K.
  • Boston Scientific made up 0.01% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #297 holding.
  • Gallagher Fiduciary Advisors first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • Gallagher Fiduciary Advisors's Boston Scientific position peaked at $792K in Q2 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.